Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP697099.RA7Wajgk_hQ9oJIuYVTLezK6LKIZBkqWJgPmbPY2ZOc8A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP697099.RA7Wajgk_hQ9oJIuYVTLezK6LKIZBkqWJgPmbPY2ZOc8A130_assertion type Assertion NP697099.RA7Wajgk_hQ9oJIuYVTLezK6LKIZBkqWJgPmbPY2ZOc8A130_head.
- NP697099.RA7Wajgk_hQ9oJIuYVTLezK6LKIZBkqWJgPmbPY2ZOc8A130_assertion description "[The addition of lapatinib to capecitabine significantly increases TTP without any evidence of a deleterious effect on patients' QOL, confirming its clinical benefit in this heavily pretreated patient population with advanced HER2+ breast cancer that has progressed on trastuzumab therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP697099.RA7Wajgk_hQ9oJIuYVTLezK6LKIZBkqWJgPmbPY2ZOc8A130_provenance.
- NP697099.RA7Wajgk_hQ9oJIuYVTLezK6LKIZBkqWJgPmbPY2ZOc8A130_assertion evidence source_evidence_literature NP697099.RA7Wajgk_hQ9oJIuYVTLezK6LKIZBkqWJgPmbPY2ZOc8A130_provenance.
- NP697099.RA7Wajgk_hQ9oJIuYVTLezK6LKIZBkqWJgPmbPY2ZOc8A130_assertion SIO_000772 19153829 NP697099.RA7Wajgk_hQ9oJIuYVTLezK6LKIZBkqWJgPmbPY2ZOc8A130_provenance.
- NP697099.RA7Wajgk_hQ9oJIuYVTLezK6LKIZBkqWJgPmbPY2ZOc8A130_assertion wasDerivedFrom befree-20140225 NP697099.RA7Wajgk_hQ9oJIuYVTLezK6LKIZBkqWJgPmbPY2ZOc8A130_provenance.
- NP697099.RA7Wajgk_hQ9oJIuYVTLezK6LKIZBkqWJgPmbPY2ZOc8A130_assertion wasGeneratedBy ECO_0000203 NP697099.RA7Wajgk_hQ9oJIuYVTLezK6LKIZBkqWJgPmbPY2ZOc8A130_provenance.